Inno Pharma LLP - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
LLPIN AAB-5628 Incorporated 03 June 2013 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Limited Liability Partnership healthcare
Data last updated
Revenue · FY 2022
₹57.38 Lakh
▼ 46% YoY
Net profit · FY 2022
₹2.23 Lakh
Net margin 3.9%
EBITDA · FY 2022
-₹32,735
EBITDA margin -0.6%
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
13 yrs
Est. 2013
Designated partners
3
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date

About Inno Pharma LLP

Data last updated:

Inno Pharma LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 03 June 2013 and has been in existence for over 13 years.

The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAB-5628. Its GSTIN is 24AAEFI2834E1ZS (Gujarat).

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Dipal Sandip Trivedi and Mital Ashit Chandaria.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.

As per the financials filed for FY 2022, the LLP reported a revenue of ₹57.38 Lakh, a decline of 46% compared to the previous year. For the same year it recorded a net profit of ₹2.23 Lakh (net margin 3.9%) and EBITDA of -₹32,735 (EBITDA margin -0.6%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 22% over five years.

Company details

LLPIN AAB-5628
Incorporation Date 03 June 2013
Total Obligation of Contribution ₹1 Lakh
ROC Ahmedabad
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025

Contact details

Inno Pharma LLP's registered office is in Ahmedabad, Gujarat. Its e-mail address is in the company report.

  • Email
  • Registered Address
    3rd Floor Office No. 12 Amrapali Axiom – 1, Ambali – Bopal Ring Road, Ahmedabad, Gujarat, India – 380058
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Inno Pharma LLP, buy the company report.

Comprehensive company report
Inno Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Inno Pharma LLP

FY 2025 filings available

Inno Pharma LLP reported revenue of ₹57.38 Lakh (down 46% YoY) for FY 2022.

Revenue · FY 2022
₹57.38 Lakh ▼ 46%
Net profit · FY 2022
₹2.23 Lakh margin 3.9%
EBITDA · FY 2022
-₹32,735 margin -0.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 3%
5 years · compounded
▲ 22%

Revenue fell 46% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹2.23 Lakh
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
Net Profit Margin3.9%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Inno Pharma LLP, buy the company report.

Designated partners of Inno Pharma LLP

Inno Pharma has 3 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Dipal Sandip TrivediDesignated Partner03 Jun 201313 Years 5 MonthsCurrent
Mital Ashit ChandariaDesignated Partner25 Oct 20242 Years 0 MonthsCurrent
Pragnesh Parshotambhai DongaDesignated Partner01 Aug 20242 Years 3 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Inno Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Inno Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAEFI2834E1ZSGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Inno Pharma LLP, buy the company report.

Recent activity

Inno Pharma LLP has 5 designated partner changes on record since 2013: 4 appointments and 1 cessation. The latest: Mital Ashit Chandaria was appointed as Designated Partner on 25 Oct 2024.

AGM
Inno Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Inno Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Mital Ashit Chandaria was appointed as Designated Partner.
Ceased
Navinchandra Lakhamshi Shah ceased to be Designated Partner.
Appointed
Pragnesh Parshotambhai Donga was appointed as Designated Partner.
Appointed
Dipal Sandip Trivedi was appointed as Designated Partner.
Appointed
Navinchandra Lakhamshi Shah was appointed as Designated Partner.
Incorporation
03 Jun 2013
Inno Pharma Llp was registered on 03 Jun 2013 with Roc Ahmedabad & aged 13 years 5 months as per MCA records.

Frequently asked questions

Inno Pharma is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 03 June 2013 (13+ years old) and is registered under LLPIN AAB-5628.

Inno Pharma has 3 current designated partners:

The latest financial statements of Inno Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Inno Pharma is 24AAEFI2834E1ZS, registered in Gujarat.

The LLPIN (Limited Liability Partnership Identification Number) of Inno Pharma is AAB-5628. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Inno Pharma was incorporated on 03 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Mital Ashit Chandaria was appointed as Designated Partner on 25 Oct 2024. Navinchandra Lakhamshi Shah ceased to be Designated Partner on 25 Oct 2024. Pragnesh Parshotambhai Donga was appointed as Designated Partner on 01 Aug 2024. Inno Pharma has 5 designated partner changes on record in total.

The registered office of Inno Pharma is at 3rd Floor Office No. 12 Amrapali Axiom – 1, Ambali – Bopal Ring Road, Ahmedabad, Gujarat, India – 380058.

Inno Pharma operates in the healthcare industry, in the medical and laboratory equipment segment.

Inno Pharma can be reached at its registered office: 3rd Floor Office No. 12 Amrapali Axiom – 1, Ambali – Bopal Ring Road, Ahmedabad, Gujarat, India – 380058.